Results 111 to 120 of about 22,402 (163)

Expression of and requirement for the NF1 gene product, neurofibromin, during cell differentiation in vivo and in vitro.

, 1995
When defective, the NF1 tumor suppressor gene causes the disease neurofibromatosis type 1 (NF1), a frequently inherited disorder characterized by numerous benign tumors of the peripheral nervous system.
Kavka, Amy
core  

Regulation of the Ras Pathway by Neurofibromin in Dendritic Spines

, 2012
Tese de doutoramento em Biologia, na especialidade de Biologia Celular, apresentada à Faculdade de Ciências da Universidade de CoimbraDiversas evidências experimentais têm sugerido que a plasticidade sináptica desempenha um papel importante na formação ...
Oliveira, Ana Isabel Ferreira Martins de
core  

NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions. [PDF]

Proc Natl Acad Sci U S A
Silva JM, Canche L, Cheng A, Young LC, McCormick F.   +4 more
europepmc   +1 more source

The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes. [PDF]

Mol Immunol, 2013
Oliver JA, Lapinski PE, Lubeck BA, Turner JS, Parada LF, Zhu Y, King PD.   +6 more
europepmc   +1 more source

Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2. [PDF]

Front Oncol
Tao E, Zhou L, Xu Z, Ren H, Yang J, Chen Y, Wang Q, Liu M, Zhang Y, Liang W, Xu S, Zhong C, Wang Z.   +12 more
europepmc   +1 more source

Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. [PDF]

Orphanet J Rare Dis
Clissa PB, Sanabani SS.
europepmc   +1 more source

Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of neurofibromatosis. [PDF]

Dis Model Mech
Miller AH, Yang Y, Schmidt N, Mathiaparanam J, Berres ME, Halloran MC.   +5 more
europepmc   +1 more source

Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target. [PDF]

Cells
Gopalan L, Na Y, Hu L, Hall A, Kim MO, Dombi E, Szabo S, Ratner N, Huang G, Wu J.   +9 more
europepmc   +1 more source

Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations. [PDF]

Mol Ther Oncol
Sammons J, Chen J, Thrasher K, Fu L, Du M, Wen H, Bostwick JR, Vinson P, Moukha-Chafiq O, Augelli-Szafran C, Keeling KM, Wallis D, Kesterson RA, Rowe SM, Bedwell DM.   +14 more
europepmc   +1 more source